BioXcel Therapeutics (BTAI)
2.55
0.00 (0.00%)
Upcoming Events
Latest Headlines
BioXcel Therapeutics (BTAI) PT Lowered to $10 at H.C. Wainwright
April 15, 2024 6:44 AM - StreetInsider
Form 8-K BioXcel Therapeutics, For: Apr 10
April 10, 2024 7:06 AM - SEC Filing
BioXcel Therapeutics (BTAI) Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
April 10, 2024 7:02 AM - StreetInsider
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
April 10, 2024 7:00 AM - Globe NewsWire
Form 4 BioXcel Therapeutics, For: Mar 14 Filed by: O'Neill Vincent
April 8, 2024 7:33 PM - SEC Filing
Form 4 BioXcel Therapeutics, For: Mar 14 Filed by: Mehta Vimal
April 8, 2024 7:32 PM - SEC Filing
Form 4 BioXcel Therapeutics, For: Mar 14 Filed by: Steinhart Richard I
April 8, 2024 7:32 PM - SEC Filing
Form 4 BioXcel Therapeutics, For: Mar 15 Filed by: Wiley Matthew T.
April 8, 2024 7:32 PM - SEC Filing
Form 4 BioXcel Therapeutics, For: Mar 14 Filed by: Yocca Frank
April 8, 2024 7:31 PM - SEC Filing
Form 4 BioXcel Therapeutics, For: Mar 14 Filed by: Rodriguez Javier
April 8, 2024 7:31 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: Steinhart Richard I
April 4, 2024 3:57 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: Rodriguez Javier
April 4, 2024 3:47 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: Wiley Matthew T.
April 4, 2024 2:51 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: Mehta Vimal
April 4, 2024 2:02 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: O'Neill Vincent
April 4, 2024 1:40 PM - SEC Filing
Form 144 BioXcel Therapeutics, Filed by: Yocca Frank
April 4, 2024 1:21 PM - SEC Filing
Form S-8 BioXcel Therapeutics,
April 3, 2024 4:56 PM - SEC Filing
Form 8-K BioXcel Therapeutics, For: Mar 25
March 25, 2024 4:05 PM - SEC Filing
Form 424B5 BioXcel Therapeutics,
March 25, 2024 4:02 PM - SEC Filing
BioXcel Therapeutics (BTAI) Announces $25 Million Registered Direct Offering
March 25, 2024 7:02 AM - StreetInsider
BioXcel Therapeutics Announces $25 Million Registered Direct Offering
March 25, 2024 7:00 AM - Globe NewsWire
Form 10-K BioXcel Therapeutics, For: Dec 31
March 22, 2024 4:42 PM - SEC Filing
BioXcel Therapeutics (BTAI) Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
March 15, 2024 7:00 AM - StreetInsider
BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
March 15, 2024 7:00 AM - Globe NewsWire
BioXcel Therapeutics (BTAI) PT Lowered to $7 at Canaccord Genuity
March 14, 2024 6:49 AM - StreetInsider
BioXcel Therapeutics (BTAI) PT Lowered to $3.50 at UBS
March 13, 2024 8:08 AM - StreetInsider
BioXcel Therapeutics (BTAI) PT Lowered to $7 at BofA Securities
March 13, 2024 6:13 AM - StreetInsider
Form 8-K BioXcel Therapeutics, For: Mar 12
March 12, 2024 7:16 AM - SEC Filing
BioXcel Therapeutics (BTAI) Tops Q4 EPS by 16c
March 12, 2024 7:01 AM - StreetInsider
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
March 12, 2024 7:00 AM - Globe NewsWire
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
March 1, 2024 7:00 AM - Globe NewsWire
UBS Downgrades BioXcel Therapeutics (BTAI) to Neutral
February 21, 2024 7:28 AM - StreetInsider
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024 8:30 AM - StreetInsider
Form 8-K BioXcel Therapeutics, For: Feb 14
February 14, 2024 7:01 AM - SEC Filing
BioXcel Therapeutics (BTAI) Terminates Proposed $60M Offering
February 13, 2024 9:01 AM - StreetInsider
BioXcel Therapeutics Announces Termination of Proposed Public Offering
February 13, 2024 9:00 AM - Globe NewsWire
Form 8-K BioXcel Therapeutics, For: Feb 12
February 12, 2024 12:46 PM - SEC Filing
Midday movers: Diamondback Energy rises, Arm goes parabolic
February 12, 2024 9:00 AM - StreetInsider
BioXcel Therapeutics (BTAI) surges on FDA fast track designation for BXCL701
February 12, 2024 7:53 AM - StreetInsider
BioXcel Therapeutics (BTAI) Granted FDA Fast Track Designation for BXCL701
February 12, 2024 7:14 AM - StreetInsider
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)
February 12, 2024 7:14 AM - Globe NewsWire
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 9, 2024 9:00 PM - StreetInsider
Form SC 13G/A BioXcel Therapeutics, Filed by: FMR LLC
February 9, 2024 8:37 AM - SEC Filing
Form 424B5 BioXcel Therapeutics,
February 8, 2024 5:28 PM - SEC Filing
Form 8-K BioXcel Therapeutics, For: Feb 08
February 8, 2024 4:53 PM - SEC Filing
BioXcel Therapeutics (BTAI) Announces Proposed Public Offering
February 8, 2024 4:01 PM - StreetInsider
BioXcel Therapeutics Announces Proposed Public Offering
February 8, 2024 4:01 PM - Globe NewsWire
Form 8-K BioXcel Therapeutics, For: Feb 07
February 8, 2024 7:09 AM - SEC Filing
Form SC 13G/A BioXcel Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
February 7, 2024 7:28 AM - SEC Filing
BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA®
February 6, 2024 7:00 AM - Globe NewsWire
BioXcel Therapeutics (BTAI) Announces USPTO's Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine
February 5, 2024 7:11 AM - StreetInsider
BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine
February 5, 2024 7:00 AM - Globe NewsWire
Form EFFECT BioXcel Therapeutics,
January 23, 2024 6:02 AM - SEC Filing
Full Article List
